Abstract:Objectives: Endoscopic submucosal dissection (ESD) has become standard method for the treatment of superficial esophageal squamous cell carcinoma (SESCC). However, post-ESD esophageal stricture often occurs if patients suffer mucosal defects of more than three-quarters of the circumference of the esophagus, and even in almost 100% of cases after wholly circumferential ESD. As always, this unresolved problem has brought difficulties and challenges to endoscopic treatment for large-scale SESCC. We conducted a prospective study to exploring new ways to prevent esophageal stricture complicating long and full circumferential ESD. Patients expected to develop a long-segment and circular mucosal defect after esophageal ESD for SESCC were eligible for the study. Preventive strategies included 1) oral administration of corticosteroids: oral prednisolone began at a dose of 30 mg/day when the patient was permitted to start oral intake,tapered gradually (30, 25, 20, 15, 10, and 5 mg for 14 days each) and then discontinued. The total amount of prednisolone application time was 12 weeks; and 2) placement of a novel self-control stricture-preventing water balloon :the balloon was 2cm in diameter when completely filled with water and the length was made according to the mucosal defect.The device was inserted about 3-4 days after ESD. After discharge, patients used the device at home and made the balloon keeping filling except for during meals. The device would be removed about 8 weeks after ESD. The primary outcome was the incidence of esophageal stricture after ESD. The secondary outcomes included the number of esophageal balloon dilation (EBD) required for the management of the stricture, and adverse events. Between February 2018 to August 2019, 31 patients who met the eligibility criteria were included and 30 patients finished the 12-week both steroid treatment and balloon placement, with one patient transferred to surgery after ESD for deep tumor infiltration. The median length of lesions was 7.9 cm (range from 6cm to 13cm). All patients were followed up for at least 3 months. Only one male patient suffered from prolonged dysphagia and did not achieve complete remission despite 6 sessions of dilation and finally received esophagectomy. All the other 29 patients did not complain of dysphagia and no stenosis was found through gastroscopy in follow up. Balloon migration happened in four patients and was resolved by timely reinsertion . No perforation, bleeding, or infection related to the ESD occurred. Over the follow-up period, no significant adverse events were observed. Strategies of oral steroid administration plus placement of a novel self-control stricture-preventing water balloon seemed to be highly effective and safe to prevent against stricture in patients after esophageal ESD for long-segment and circumferential SESCC.4 days after ESD(the same case), a novel self-control stricture-preventing water balloon was inserted.View Large Image Figure ViewerDownload Hi-res image Download (PPT)

Oral higher dose prednisolone to prevent stenosis after endoscopic submucosal dissection for early esophageal cancer

Efficacy of Oral Prednisone Acetate for Prevention of Esophageal Stenosis after Endoscopic Submucosal Dissection

Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma

Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma

Efficacy of short period, low dose oral prednisolone for the prevention of stricture after circumferential endoscopic submucosal dissection (ESD) for esophageal cancer

[Effect and mechanism of glucocorticoids in preventing stenosis after esophageal endoscopic submucosal dissection]

Effect of oral prednisolone on esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a case report

Long-term efficacy and safety of intralesional steroid injection plus oral steroid administration in preventing stricture after endoscopic submucosal dissection for esophageal epithelial neoplasms

High-dose Dexamethasone May Prevent Esophageal Stricture after Endoscopic Submucosal Dissection.

Preventing esophageal strictures with steroids after endoscopic submucosal dissection in superficial esophageal neoplasm

Administration of oral prednisolone to prevent esophageal stricture after balloon-type radiofrequency ablation for ultralong-segment esophageal neoplasia

Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma

Efficacy of oral steroid gel in preventing esophageal stricture after extensive endoscopic submucosal dissection: a randomized controlled trial

Submucosal steroid pre-injection strategy to prevent oesophageal stricture after circumferential endoscopic submucosal dissection

Preventive Strategies Of Esophageal Stricture After Endoscopic Submucosal Dissection For Long-Segment And Circumferencial Esophageal Squamous Carcinoma: A Prospective Exploratory Study

Predictors of stricture after endoscopic submucosal dissection of the esophagus and steroids application

Effects of steroid use for stenosis prevention after wide endoscopic submucosal dissection for gastric neoplasm

Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone

Prophylactic steroid administration against strictures is not enough for mucosal defects involving the entire circumference of the esophageal lumen after esophageal endoscopic submucosal dissection (ESD)

Efficacy of hydrocortisone sodium succinate and aluminum phosphate gel for stricture prevention after ≥3/4 circumferential endoscopic submucosal dissection

Prevention of esophageal stricture after endoscopic submucosal dissection of squamous cell carcinoma using a 20-French nasogastric tube combined with oral steroid administration